John Liatos serves as Executive at Kintara Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, John Liatos has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 19, 2020 involved purchasing 196,750 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 19, 2020 | KTRA | $0 | Purchase | 196,750 | $N/A | Discretionary |
John Liatos currently holds 196,750 shares of Kintara Therapeutics, Inc. (KTRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Liatos has been a net neutral trader of KTRA stock. They have purchased $0 and sold $0 worth of shares.
John Liatos's most recent insider trade was on Aug 19, 2020, when they purchased 196,750 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted